Journal Browser

Go Edit a Special Issue


Special Issue Title:

Big Data and Status Asthmaticus

Deadline for manuscript submissions: 31 August 2021

Print Special Issue Flyer (2)

Special Issue Editor

  • Guest Editor

    Dr. Herng-Ching LinE-MailWebsite

    Professor of School of Healthcare Administration, Taipei Medical University, Taiwan

    Interests: Health policy, Epidemiology, Big data analytics: Asthma

Special Issue Information

Background: Status asthmaticus has been a serious global health problem with major public health consequences for patients of all ages. Since the past decade, progress such as the identification of genetic and environmental risk factors correlated to asthma has been made; yet, despite researchers’ focus on preventing and controlling symptoms of the disease, there has been a sharp global rise in the prevalence of childhood status asthmaticus, especially in developing countries. Not only affecting children and teenagers, status asthmaticus has been a serious issue for many adults and the elderly population who still experience the symptoms of asthma attacks on a daily basis. Although status asthmaticus currently cannot be cured, appropriate prevention strategy and treatment management can be undertaken to control the disease. Along with the rapidly-growing environmental, population, clinical, and public health datasets, modern big data analytic techniques have allowed clinicians and health professionals to construct innovative clinical decision models. Thus, it is crucial for clinicians and policy makers to find ways of optimizing status asthmaticus treatment and enhance the delivery of effective care through big data analytics, ultimately enabling people to enjoy a healthy quality of life.


Importance: A better understanding of status asthmaticus may eventually lead to opportunities for primary prevention and treatment of status asthmaticus through the use of big data analytics.


Goal: Our goal includes developing an increasing understanding of status asthmaticus and its underlying mechanisms, improving status asthmaticus diagnoses and treatments, developing status asthmaticus prevention strategies by providing an authoritative open forum on asthma and related conditions through big data analytics.


Status asthma, Big data, Big data analytics, Epidemiology

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Signa Viate is an international peer-reviewed open access journal published by MRE Press. As of January 2021, Signa Vitae will change to a bimonthly journal. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Plan Papers (0 papers)

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time